UnknownNCT05350462
Adoption of L-PZQ for Schistosomiasis by Endemic Counties - Social Science Research Study
Studying Schistosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Technical University of Munich
- Principal Investigator
- Mary Nyamongo, Dr.African Institute for Health and Development
- Intervention
- Community pilot L-PZQ distribution - intervention is NOT part of this observational study(behavioral)
- Enrollment
- 225 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2021 – 2025
Study locations (3)
- Université Félix Houphouët-Boigny, Abidjan, Côte d’Ivoire
- African Institute for Health and Development, Nairobi, Kenya
- Makerere University, Kampala, Uganda
Collaborators
African Institute for Health and Development · Makerere University · European and Developing Countries Clinical Trials Partnership (EDCTP) · Global Health Innovative Technology Fund · Stichting Lygature · Université Félix Houphouët-Boigny · Kenya Medical Research Institute · Swiss Tropical & Public Health Institute · SCI Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05350462 on ClinicalTrials.govOther trials for Schistosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06698510Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention StudyPeter Steinmann
- RECRUITINGNANCT06873308Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic SchistosomiasisIRCCS Sacro Cuore Don Calabria di Negrar